1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Dry Eye Disease Market - Growth, Trends, and Forecast (2019 - 2024)

Dry Eye Disease Market - Growth, Trends, and Forecast (2019 - 2024)

  • June 2019
  • 117 pages
  • ID: 5790925
  • Format: PDF
  • By Mordor Intelligence LLP

Summary

Table of Contents

Search Inside

Market Overview
The Dry Eye Disease market studied was valued at USD 4,539.22 million in 2018, and is expected to reach USD 6,175.96 million by 2024, with an anticipated CAGR of 5.23%, during the forecast period (2019-2024). Several factors may be associated with the growth of dry eye related diseases, such as aging, a decrease in the supportive hormones, systemic inflammatory diseases, ocular surfaces diseases or surgeries affecting the cholinergic nerves, which stimulate tear secretion.

A significant percentage of the global population (middle age to older age) suffer from dry eye syndrome. It is particularly more common among women than in men. Additionally, working for long hours on computer screens as well as long term contact lens use cause dry eye. In addition, several manufacturers are exploring the alternative drug class or procedure, with improvement in diagnostic tools, to identify and enhance the tear stimulating factors, which drives the importance of dry eye disease correction. Thus, the rise in geriatric population and the technological advancements and promising pipeline products will further help in the market growth.

Scope of the Report
Dry eye disease refers to a disturbance of the lacrimal functional unit, which comprises of the lacrimal glands, ocular surface (cornea, conjunctiva and meibomian glands) and lids, and the sensory and motor nerves that connect them. There are several ocular manifestations for which several dry eye products are used for the treatment of the disease.

Key Market Trends
Corticosteroid Drugs is Expected to Grow with a Decent CAGR in the Anti-Inflammatory Drugs Segment

Corticosteroids are effective anti-inflammatory drugs, widely available, that rapidly relieve the symptoms and signs of moderate and severe dry eye. These drugs are highly useful in short term efficacy and thus prescribed mostly for acute cases of dry eye diseases. However, with the long term usage of these drugs, there are major side effects, such as intraocular pressure elevation and cataract progression. Two of the major companies established in this segment are Bausch Health and Allergan. Often, these companies, as well as doctors, recommend corticosteroid along with antibiotic therapy.

Some of the common interventions include dietary omega-3 essential fatty acids, such as fish oils or flaxseed oil; or the use of lipid-based artificial tears to augment the deficient lipid layer; and/or a short course of a topical ester-based corticosteroid, in order to address the inflammatory component of the dry eye. Over the forecast period, with the severity of disease at the chronic level of the disease, the corticosteroids are most extensively used. Their share is thus considered to be largest, growing at a steady CAGR over the forecast period.

Asia Pacific is expected to grow with High CAGR and Expected to do Same in the Forecast Period

Geographically, the North American region holds a major share, whereas the Asia-Pacific region is estimated to be the fastest growing. Several factors, such as hospital infrastructure, procuring new technology devices for diagnosis of diseases, early market approval of the product, a large number of ophthalmic surgeries, early awareness in the society, drive the market in the North American region. In Asia, a large number of generic production, good distribution of local and international players, and the fast economic growth of the country are factors driving the growth of the studied market.

Competitive Landscape
The Dry Eye Disease market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising geriatric population and high prevalence of diseases, few other smaller players are expected to enter into the market in the coming years. Some of the major players of the market are Allergan PLC, Novartis AG, Santen Pharmaceutical Co. Ltd, OASIS Medical, and Bausch Health are among others.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($4250)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Conjunctivitis Global Clinical Trials Review, H1, 2019

Conjunctivitis Global Clinical Trials Review, H1, 2019

  • $ 2500
  • April 2019

Conjunctivitis Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Conjunctivitis Global Clinical Trials Review, H1, 2019" provides an overview of Conjunctivitis clinical ...

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019

  • $ 2500
  • May 2019

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019" provides ...

Corneal Neovascularization Global Clinical Trials Review, H1, 2019

Corneal Neovascularization Global Clinical Trials Review, H1, 2019

  • $ 2500
  • April 2019

Corneal Neovascularization Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Corneal Neovascularization Global Clinical Trials Review, H1, 2019" provides an overview ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on